Other Species / Isoforms
  Zyxin (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R5-m1
___MAAPrPsPAISV
0 1
Zyxin (human) ___MAAPrPsPAISV R5-m1
Zyxin (mouse) ___MAAPRPPPAISV R5
Zyxin (rat) ___MAAPRPPPAISV R5
Zyxin (cow) ___MAAPRPPRAISV R5
S7-p
_MAAPrPsPAISVsV
Upstream
0 4
Treatment
  • ischemia
Zyxin (human) _MAAPrPsPAISVsV S7-p
Zyxin (mouse) _MAAPRPPPAISVsV P7
Zyxin (rat) _MAAPRPPPAISVSV P7
Zyxin (cow) _MAAPRPPRAISVSA P7
S13-p
PsPAISVsVsAPAFy
0 2
Zyxin (human) PsPAISVsVsAPAFy S13-p
Zyxin (mouse) PPPAISVsVSAPAFY S13-p
Zyxin (rat) PPPAISVSVSAPAFY S13
Zyxin (cow) PRPPRAISVSAPVFY S11
S15-p
PAISVsVsAPAFyAP
Upstream
0 8
Treatment
  • ischemia
Zyxin (human) PAISVsVsAPAFyAP S15-p
Zyxin (mouse) PAISVsVSAPAFYAP S15
Zyxin (rat) PAISVSVSAPAFYAP S15
Zyxin (cow) PPRAISVSAPVFYAP S13
Y20-p
sVsAPAFyAPQkkFG
0 22
Zyxin (human) sVsAPAFyAPQkkFG Y20-p
Zyxin (mouse) sVSAPAFYAPQKKFA Y20
Zyxin (rat) SVSAPAFYAPQKkFA Y20
Zyxin (cow) SVSAPVFYAPQKKFA Y18
K24-ac
PAFyAPQkkFGPVVA
0 31
Zyxin (human) PAFyAPQkkFGPVVA K24-ac
Zyxin (mouse) PAFYAPQKKFAPVVA K24
Zyxin (rat) PAFYAPQKkFAPVVA K24
Zyxin (cow) PVFYAPQKKFAPVVA K22
K25-ac
AFyAPQkkFGPVVAP
0 6
Zyxin (human) AFyAPQkkFGPVVAP K25-ac
Zyxin (mouse) AFYAPQKKFAPVVAP K25
Zyxin (rat) AFYAPQKkFAPVVAP K25-ac
Zyxin (cow) VFYAPQKKFAPVVAP K23
K25-m2
AFyAPQkkFGPVVAP
0 1
Zyxin (human) AFyAPQkkFGPVVAP K25-m2
Zyxin (mouse) AFYAPQKKFAPVVAP K25
Zyxin (rat) AFYAPQKKFAPVVAP K25
Zyxin (cow) VFYAPQKKFAPVVAP K23
S44-p
NPFRPGDsEPPPAPG
0 1
Zyxin (human) NPFRPGDsEPPPAPG S44-p
Zyxin (mouse) NPFRPGDSEPPVAAG S44
Zyxin (rat) NPFRPGDSEsPVAAG S44
Zyxin (cow) NPFRPGDSEPPPAAG S42
P46
FRPGDsEPPPAPGAQ
0 1
Zyxin (human) FRPGDsEPPPAPGAQ P46
Zyxin (mouse) FRPGDSEPPVAAGAQ P46
Zyxin (rat) FRPGDSEsPVAAGAQ S46-p
Zyxin (cow) FRPGDSEPPPAAGAQ P44
S116-p
LEEEIFPsPPPPPEE
0 1
Zyxin (human) LEEEIFPsPPPPPEE S116-p
Zyxin (mouse) LEEDIFPSPPPPLEE S117
Zyxin (rat) LEEDIFPSPPPPLEE S117
Zyxin (cow) LEEEIFPSPPPPLVE S114
S142-p
PQPREKVssIDLEId
Upstream
Downstream
1 11
Zyxin (human)
S142-p
Zyxin (rat)
S143-p
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • EGF
  • ischemia
  • nocodazole
  • U0126
Zyxin (human) PQPREKVssIDLEId S142-p
Zyxin (mouse) PQPREKVCsIDLEID C143
Zyxin (rat) PQPREKVssIDLEID S143-p
Zyxin (cow) SQPREKVSSIDLEID S140
S143-p
QPREKVssIDLEIds
Upstream
0 31
Zyxin (human)
S143-p
Zyxin (rat)
S144-p
Treatment
  • EGF
  • metastatic potential
Zyxin (human) QPREKVssIDLEIds S143-p
Zyxin (mouse) QPREKVCsIDLEIDS S144-p
Zyxin (rat) QPREKVssIDLEIDS S144-p
Zyxin (cow) QPREKVSSIDLEIDS S141
D149-ca
ssIDLEIdsLSSLLD
0 1
Zyxin (human) ssIDLEIdsLSSLLD D149-ca
Zyxin (mouse) CsIDLEIDSLSSLLD D150
Zyxin (rat) ssIDLEIDSLSSLLD D150
Zyxin (cow) SSIDLEIDSLSSLLD D147
S150-p
sIDLEIdsLSSLLDD
Upstream
0 4
Treatment
  • nocodazole
Zyxin (human) sIDLEIdsLSSLLDD S150-p
Zyxin (mouse) sIDLEIDSLSSLLDD S151
Zyxin (rat) sIDLEIDSLSSLLDD S151
Zyxin (cow) SIDLEIDSLSSLLDD S148
T159
SSLLDDMTKNDPFkA
0 1
Zyxin (human) SSLLDDMTKNDPFkA T159
Zyxin (mouse) SSLLDDMtKNDPFKA T160-p
Zyxin (rat) SSLLDDMTKNDPFKA T160
Zyxin (cow) SSLLDDMTKNDPFKA T157
K165-ac
MTKNDPFkARVssGy
0 1
Zyxin (human) MTKNDPFkARVssGy K165-ac
Zyxin (mouse) MtKNDPFKARVssGY K166
Zyxin (rat) MTKNDPFKARVSSGY K166
Zyxin (cow) MTKNDPFKARVSSGY K163
K165-ub
MTKNDPFkARVssGy
0 1
Zyxin (human) MTKNDPFkARVssGy K165-ub
Zyxin (mouse) MtKNDPFKARVssGY K166
Zyxin (rat) MTKNDPFKARVSSGY K166
Zyxin (cow) MTKNDPFKARVSSGY K163
K165-m1
MTKNDPFkARVssGy
0 1
Zyxin (human) MTKNDPFkARVssGy K165-m1
Zyxin (mouse) MtKNDPFKARVssGY K166
Zyxin (rat) MTKNDPFKARVSSGY K166
Zyxin (cow) MTKNDPFKARVSSGY K163
S169-p
DPFkARVssGyVPPP
Upstream
0 12
Treatment
  • gefitinib
  • nocodazole
Zyxin (human) DPFkARVssGyVPPP S169-p
Zyxin (mouse) DPFKARVssGYVPPP S170-p
Zyxin (rat) DPFKARVSSGYVPPP S170
Zyxin (cow) DPFKARVSSGYVPPP S167
S170-p
PFkARVssGyVPPPV
0 5
Zyxin (human) PFkARVssGyVPPPV S170-p
Zyxin (mouse) PFKARVssGYVPPPV S171-p
Zyxin (rat) PFKARVSSGYVPPPV S171
Zyxin (cow) PFKARVSSGYVPPPV S168
Y172-p
kARVssGyVPPPVAt
Upstream
0 54
Treatment
  • Su11274
Zyxin (human) kARVssGyVPPPVAt Y172-p
Zyxin (mouse) KARVssGYVPPPVAT Y173
Zyxin (rat) KARVSSGYVPPPVAT Y173
Zyxin (cow) KARVSSGYVPPPVTT Y170
T179-p
yVPPPVAtPFSSKSS
Upstream
0 11
Treatment
  • BI2536
  • MLN8054
  • nocodazole
Zyxin (human) yVPPPVAtPFSSKSS T179-p
Zyxin (mouse) YVPPPVATPFVPKPS T180
Zyxin (rat) YVPPPVATPFVPKPS T180
Zyxin (cow) YVPPPVTTPFISKSN T177
K201-m1
TAPLPPWksPSSsQP
0 1
Zyxin (human) TAPLPPWksPSSsQP K201-m1
Zyxin (mouse) TAPLPPWKTPSSSQP K202
Zyxin (rat) TAPLPPWKAPSSSQP K202
Zyxin (cow) TAPLPPWKSPSSSQP K199
S202-p
APLPPWksPSSsQPL
0 1
Zyxin (human) APLPPWksPSSsQPL S202-p
Zyxin (mouse) APLPPWKTPSSSQPP T203
Zyxin (rat) APLPPWKAPSSSQPP A203
Zyxin (cow) APLPPWKSPSSSQPV S200
S206-p
PWksPSSsQPLPQVP
0 1
Zyxin (human) PWksPSSsQPLPQVP S206-p
Zyxin (mouse) PWKTPSSSQPPPQPQ S207
Zyxin (rat) PWKAPSSSQPPPQPQ S207
Zyxin (cow) PWKSPSSSQPVSQAQ S204
S246
QSQTQPVSLANtQPr
0 1
Zyxin (human) QSQTQPVSLANtQPr S246
Zyxin (mouse) HVQPQPVsSANTQPr S237-gl
Zyxin (rat) HVQPQSVSSANTQPr S237
Zyxin (cow) QAPPQPVPLATTQPR P236
T250-p
QPVSLANtQPrGPPA
0 1
Zyxin (human) QPVSLANtQPrGPPA T250-p
Zyxin (mouse) QPVsSANTQPrGPLS T241
Zyxin (rat) QSVSSANTQPrGPLS T241
Zyxin (cow) QPVPLATTQPRGPLA T240
R253-m1
SLANtQPrGPPAssP
0 9
Zyxin (human) SLANtQPrGPPAssP R253-m1
Zyxin (mouse) sSANTQPrGPLSQAP R244-m1
Zyxin (rat) SSANTQPrGPLSQAP R244-m1
Zyxin (cow) PLATTQPRGPLAPSP R243
R253
SLANtQPRGPPAssP
0 9
Zyxin (human) SLANtQPRGPPAssP R253
Zyxin (mouse) sSANTQPrGPLSQAP R244-m2
Zyxin (rat) SSANTQPRGPLSQAP R244
Zyxin (cow) PLATTQPRGPLAPSP R243
S258-p
QPrGPPAssPAPAPk
0 7
Zyxin (human) QPrGPPAssPAPAPk S258-p
Zyxin (mouse) QPrGPLSQAPtPAPK Q249
Zyxin (rat) QPrGPLSQAPTPAPK Q249
Zyxin (cow) gap -
S259-p
PrGPPAssPAPAPkF
Upstream
0 44
Treatment
  • HB-EGF
  • LPA
  • nocodazole
Zyxin (human) PrGPPAssPAPAPkF S259-p
Zyxin (mouse) PrGPLSQAPtPAPKF A250
Zyxin (rat) PrGPLSQAPTPAPKF A250
Zyxin (cow) gap -
A261
GPPAssPAPAPkFsP
0 2
Zyxin (human) GPPAssPAPAPkFsP A261
Zyxin (mouse) GPLSQAPtPAPKFAP T252-p
Zyxin (rat) GPLSQAPTPAPKFAP T252
Zyxin (cow) PRGPLAPSPAPKFsP S249
K265-ac
ssPAPAPkFsPVtPk
0 1
Zyxin (human) ssPAPAPkFsPVtPk K265-ac
Zyxin (mouse) QAPtPAPKFAPVAPK K256
Zyxin (rat) QAPTPAPKFAPVAPK K256
Zyxin (cow) LAPSPAPKFsPVTPK K253
K265-ub
ssPAPAPkFsPVtPk
0 2
Zyxin (human) ssPAPAPkFsPVtPk K265-ub
Zyxin (mouse) QAPtPAPKFAPVAPK K256
Zyxin (rat) QAPTPAPKFAPVAPK K256
Zyxin (cow) LAPSPAPKFsPVTPK K253
S267-p
PAPAPkFsPVtPkFt
Upstream
0 54
Treatment
  • anti-CD3
  • nocodazole
  • U0126
Zyxin (human) PAPAPkFsPVtPkFt S267-p
Zyxin (mouse) PtPAPKFAPVAPKFT A258
Zyxin (rat) PTPAPKFAPVAPKFT A258
Zyxin (cow) PSPAPKFsPVTPKFT S255-p
T270-p
APkFsPVtPkFtPVA
Upstream
0 44
Treatment
  • taxol
  • U0126
Zyxin (human) APkFsPVtPkFtPVA T270-p
Zyxin (mouse) APKFAPVAPKFTPVV A261
Zyxin (rat) APKFAPVAPKFTPVA A261
Zyxin (cow) APKFsPVTPKFTPVA T258
K272-ac
kFsPVtPkFtPVAsk
0 1
Zyxin (human) kFsPVtPkFtPVAsk K272-ac
Zyxin (mouse) KFAPVAPKFTPVVsK K263
Zyxin (rat) KFAPVAPKFTPVASk K263
Zyxin (cow) KFsPVTPKFTPVASK K260
K272-ub
kFsPVtPkFtPVAsk
0 2
Zyxin (human) kFsPVtPkFtPVAsk K272-ub
Zyxin (mouse) KFAPVAPKFTPVVsK K263
Zyxin (rat) KFAPVAPKFTPVASk K263
Zyxin (cow) KFsPVTPKFTPVASK K260
K272-m1
kFsPVtPkFtPVAsk
0 3
Zyxin (human) kFsPVtPkFtPVAsk K272-m1
Zyxin (mouse) KFAPVAPKFTPVVsK K263
Zyxin (rat) KFAPVAPKFTPVASk K263
Zyxin (cow) KFsPVTPKFTPVASK K260
T274-p
sPVtPkFtPVAskFs
Upstream
0 17
Treatment
  • BI2536
  • MLN8054
  • nocodazole
  • taxol
Zyxin (human) sPVtPkFtPVAskFs T274-p
Zyxin (mouse) APVAPKFTPVVsKFs T265
Zyxin (rat) APVAPKFTPVASkFs T265
Zyxin (cow) sPVTPKFTPVASKFs T262
S278-p
PkFtPVAskFsPGAP
0 5
Zyxin (human) PkFtPVAskFsPGAP S278-p
Zyxin (mouse) PKFTPVVsKFsPGAP S269-p
Zyxin (rat) PKFTPVASkFsPGAP S269
Zyxin (cow) PKFTPVASKFsPGAP S266
K279-ac
kFtPVAskFsPGAPG
Upstream
0 23
Treatment
  • vorinostat
Zyxin (human) kFtPVAskFsPGAPG K279-ac
Zyxin (mouse) KFTPVVsKFsPGAPs K270
Zyxin (rat) KFTPVASkFsPGAPS K270-ac
Zyxin (cow) KFTPVASKFsPGAPG K267
K279-ub
kFtPVAskFsPGAPG
0 5
Zyxin (human) kFtPVAskFsPGAPG K279-ub
Zyxin (mouse) KFTPVVsKFsPGAPs K270
Zyxin (rat) KFTPVASKFsPGAPS K270
Zyxin (cow) KFTPVASKFsPGAPG K267
K279-m1
kFtPVAskFsPGAPG
0 1
Zyxin (human) kFtPVAskFsPGAPG K279-m1
Zyxin (mouse) KFTPVVsKFsPGAPs K270
Zyxin (rat) KFTPVASKFsPGAPS K270
Zyxin (cow) KFTPVASKFsPGAPG K267
S281-p
tPVAskFsPGAPGGs
Upstream
0 57
Treatment
  • anti-CD3
  • AZD1152
  • BI2536
  • dasatinib
  • EGF
  • ischemia
  • metastatic potential
  • nocodazole
  • ZM447439
Zyxin (human) tPVAskFsPGAPGGs S281-p
Zyxin (mouse) TPVVsKFsPGAPsGP S272-p
Zyxin (rat) TPVASkFsPGAPSGP S272-p
Zyxin (cow) TPVASKFsPGAPGGP S269-p
G286
kFsPGAPGGsGsQPN
0 2
Zyxin (human) kFsPGAPGGsGsQPN G286
Zyxin (mouse) KFsPGAPsGPGPQPN S277-p
Zyxin (rat) kFsPGAPSGPGPQPS S277
Zyxin (cow) KFsPGAPGGPGSQPH G274
S288-p
sPGAPGGsGsQPNQk
0 10
Zyxin (human) sPGAPGGsGsQPNQk S288-p
Zyxin (mouse) sPGAPsGPGPQPNQK P279
Zyxin (rat) sPGAPSGPGPQPSQK P279
Zyxin (cow) sPGAPGGPGSQPHQK P276
S290-p
GAPGGsGsQPNQkLG
0 9
Zyxin (human) GAPGGsGsQPNQkLG S290-p
Zyxin (mouse) GAPsGPGPQPNQKMV P281
Zyxin (rat) GAPSGPGPQPSQKSV P281
Zyxin (cow) GAPGGPGSQPHQKLG S278
K295-ub
sGsQPNQkLGHPEAL
0 1
Zyxin (human) sGsQPNQkLGHPEAL K295-ub
Zyxin (mouse) PGPQPNQKMVPPDAP K286
Zyxin (rat) PGPQPSQKSVPLEAP K286
Zyxin (cow) PGSQPHQKLGPPEAP K283
S303-p
LGHPEALsAGtGsPQ
0 4
Zyxin (human) LGHPEALsAGtGsPQ S303-p
Zyxin (mouse) MVPPDAPSSVsTGsP S294
Zyxin (rat) SVPLEAPSSVGTGSP S294
Zyxin (cow) LGPPEAPSSTGTGSP S291
G305
HPEALsAGtGsPQPP
0 1
Zyxin (human) HPEALsAGtGsPQPP G305
Zyxin (mouse) PDAPSSVsTGsPQPP S297-p
Zyxin (rat) LEAPSSVGTGSPQPP G297
Zyxin (cow) PEAPSSTGTGSPQPP G294
T306-p
PEALsAGtGsPQPPs
0 7
Zyxin (human) PEALsAGtGsPQPPs T306-p
Zyxin (mouse) DAPSSVsTGsPQPPS T298
Zyxin (rat) EAPSSVGTGSPQPPS T298
Zyxin (cow) EAPSSTGTGSPQPPS T295
S308-p
ALsAGtGsPQPPsFt
Upstream
0 28
Treatment
  • nocodazole
Zyxin (human) ALsAGtGsPQPPsFt S308-p
Zyxin (mouse) PSSVsTGsPQPPSFT S300-p
Zyxin (rat) PSSVGTGSPQPPSFT S300
Zyxin (cow) PSSTGTGSPQPPSFT S297
S313-p
tGsPQPPsFtyAQQR
0 4
Zyxin (human) tGsPQPPsFtyAQQR S313-p
Zyxin (mouse) TGsPQPPSFTYAQQK S305
Zyxin (rat) TGSPQPPSFTYAQQK S305
Zyxin (cow) TGSPQPPSFTYAQQK S302
T315-p
sPQPPsFtyAQQREK
0 8
Zyxin (human) sPQPPsFtyAQQREK T315-p
Zyxin (mouse) sPQPPSFTYAQQKEK T307
Zyxin (rat) SPQPPSFTYAQQKEk T307
Zyxin (cow) SPQPPSFTYAQQKEK T304
Y316-p
PQPPsFtyAQQREKP
Upstream
0 206
Treatment
  • ephrin_B1
Zyxin (human) PQPPsFtyAQQREKP Y316-p
Zyxin (mouse) PQPPSFTYAQQKEKP Y308
Zyxin (rat) PQPPSFTYAQQKEkP Y308
Zyxin (cow) PQPPSFTYAQQKEKP Y305
K322
tyAQQREKPRVQEkQ
0 1
Zyxin (human) tyAQQREKPRVQEkQ K322
Zyxin (mouse) TYAQQKEKPLVQEKQ K314
Zyxin (rat) TYAQQKEkPLVQEKQ K314-ac
Zyxin (cow) TYAQQKEKPQVQEKQ K311
K328-ub
EKPRVQEkQHPVPPP
0 3
Zyxin (human) EKPRVQEkQHPVPPP K328-ub
Zyxin (mouse) EKPLVQEKQHPQPPP K320
Zyxin (rat) EkPLVQEKQHPLPPP K320
Zyxin (cow) EKPQVQEKQHPVPPP K317
R343-m1
AQNQNQVrsPGAPGP
0 2
Zyxin (human) AQNQNQVrsPGAPGP R343-m1
Zyxin (mouse) AQNQNQVRsPGGPGP R335
Zyxin (rat) AQNQNQVRsPGGPGP R335
Zyxin (cow) TQNQNQVRPAGAPGP R332
S344-p
QNQNQVrsPGAPGPL
Upstream
0 89
Treatment
  • angiotensin_2
  • anti-CD3
  • dasatinib
  • ischemia
  • lapatinib
  • LRRK2-IN-1
  • nocodazole
  • selumetinib
  • vemurafenib
Zyxin (human) QNQNQVrsPGAPGPL S344-p
Zyxin (mouse) QNQNQVRsPGGPGPL S336-p
Zyxin (rat) QNQNQVRsPGGPGPL S336-p
Zyxin (cow) QNQNQVRPAGAPGPL P333
T352-p
PGAPGPLtLKEVEEL
0 2
Zyxin (human) PGAPGPLtLKEVEEL T352-p
Zyxin (mouse) PGGPGPLtLKEVEEL T344-p
Zyxin (rat) PGGPGPLTLKEVEEL T344
Zyxin (cow) AGAPGPLTLKEVEEL T341
S505-p
KQYAPRCsVCSEPIM
0 4
Zyxin (human) KQYAPRCsVCSEPIM S505-p
Zyxin (mouse) KQYAPRCsVCSEPIM S497-p
Zyxin (rat) KQYAPRCSVCSEPIM S497
Zyxin (cow) KQYAPRCSVCAEPIM S494
K528-ac
VRVVALDkNFHMKCY
0 2
Zyxin (human) VRVVALDkNFHMKCY K528-ac
Zyxin (mouse) VRVVALDKNFHMKCY K520
Zyxin (rat) VRVVALDKNFHMKCY K520
Zyxin (cow) VRVVALDKNFHMKCY K517